44P BOLD-100-001: A phase II study of BOLD-100 in combination with FOLFOX in advanced mCRC patients that have failed at least two prior lines of therapy

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 35; p. S22
Main Authors O'Kane, G.M., Spratlin, J., Oh, D-Y., Rha, S.Y., McWhirter, E., Elimova, E., Kavan, P., Choi, M.K., Kim, D., Goodwin, R.A., Hecht, J.R., Koo, D-H., Halani, K., McAllister, R., Jones, M., Snow, M.D., Lemmerick, Y., Spera, G., Pankovich, J.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.06.2024
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2024.05.055